Clovis Oncology Inc reports results for the quarter ended in June - Earnings Summary

Clovis Oncology

08/08/2022 14:32

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly
adjusted loss
of 50 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 41 cents per share.
    * Revenue fell 12.7% to $32.14 million from a year ago;
analysts
expected $37.03 million. 
    * Clovis Oncology Inc's reported EPS for the quarter was a
loss
of 50 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clovis Oncology Inc shares had fallen by 7.8% this
quarter and
lost 38.7% so far this year.
    * The company reported a quarterly loss of $71.33 million.
    * Wall Street's median 12-month price target for Clovis
Oncology
Inc is $3.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 8
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.41          -0.50          Missed
 Mar. 31 2022      -0.43          -0.44          Missed
 Dec. 31 2021      -0.57          -0.48          Beat
 Sep. 30 2021      -0.48          -0.56          Missed